Reverse Medical is a medical device company focused on vascular disease management. Through the acquisition, Covidien will expand its existing portfolio to include vascular technologies to help the company compete in the worldwide vascular embolization market, according to a news release.
Financial terms of the acquisition were not disclosed.
In June, Medtronic entered a definitive agreement to acquire Covidien for $42.9 billion.
More articles on acquisitions:
Roche to buy InterMune for $8.3B
Duke LifePoint, Conemaugh Health reach definitive acquisition agreement
5 recent hospital transactions and partnerships
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
